Kventiax SR 50 mg tablete s produljenim oslobađanjem
Name | Kventiax SR 50 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-515419067 |
Active Substance | kvetiapinfumarat |
Composition | svaka tableta s produljenim oslobađanjem sadrži 50 mg kvetiapina u obliku kvetiapinfumarata |
Pharmaceutical Form | tableta s produljenim oslobađanjem |
Packaging [MA Number for Packaging] | 10 tableta u blisteru, u kutiji [HR-H-515419067-01] 30 tableta u blisteru, u kutiji [HR-H-515419067-02] 50 tableta u blisteru, u kutiji [HR-H-515419067-03] 60 tableta u blisteru, u kutiji [HR-H-515419067-04] 90 tableta u blisteru, u kutiji [HR-H-515419067-05] 100 tableta u blisteru, u kutiji [HR-H-515419067-06] |
Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija |
Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
Marketing Authorisation Date | 17.07.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/19-02/165 |
Registration Number | 381-12-01/38-20-05 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N05AH04 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Educational materials for healthcare professionals |
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2 |